{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This randomised controlled trial was conducted at a tertiary care hospital."
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Participants were randomised using a computer-generated sequence, with allocation concealed by sealed envelopes."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adult patients undergoing cardiac surgery with CPB. Eligibility criteria included age 18-75 years and no pre-existing renal disease."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received optimized CPB procedures, while the control group underwent standard CPB."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to evaluate the impact of CPB on AKI incidence and explore preventive strategies."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of AKI within 7 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Participants were randomised using a computer-generated sequence, with allocation concealed by sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 98 participants in the intervention group and 97 in the control group, using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The intervention group showed a reduced AKI incidence (20% vs. 35%, p = 0.02)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No severe adverse events were reported; mild gastrointestinal side-effects occurred in 3% of the intervention group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: This study was funded by the National Institutes of Health."
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}